[Signal pathways of leukemia cell proliferation induced by ouabain]

Jia-Wei Xu1, Run-Ming Jin, Yan Bai

  • 1Department of Pediatrics, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei Province, China.

Insights

Ouabain at low doses promotes leukemia cell survival by up-regulating Na(+), K(+)-ATPase alpha1 subunit. Signal pathway inhibitors block this proliferation, indicating Src kinase and ERK1/2 pathways mediate ouabain

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Leukemia cell growth is a complex process involving various signaling pathways.
  • Ouabain, a cardiac glycoside, has demonstrated potential anti-cancer properties.
  • Understanding the specific pathways involved in ouabain's effect on leukemia is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the impact of ouabain and specific signal pathway inhibitors on leukemia cell growth.
  • To elucidate the role of signaling pathways in ouabain-induced proliferation and apoptosis of leukemia cells.
  • To explore the expression of Na(+), K(+)-ATPase alpha1 subunit in leukemia cells treated with ouabain.

Main Methods:

  • Cell viability was assessed using MTT assays after treatment with ouabain and pathway inhibitors.
  • Gene and protein expression of Na(+), K(+)-ATPase alpha1 subunit were evaluated by RT-PCR and Western blot.
  • Specific inhibitors (PP2 and PD98059) were used to block Src kinase and ERK1/2 signaling pathways.

Main Results:

  • Low concentration ouabain (10 nmol/L) enhanced survival rates in lymphocytic leukemia (Jhhan) and megakaryocytic leukemia (M07e) cell lines.
  • Ouabain treatment led to increased expression of the Na(+), K(+)-ATPase alpha1 subunit in these leukemia cells.
  • Inhibition of Src kinase (PP2) and ERK1/2 (PD98059) pathways partially or significantly reduced ouabain-induced leukemia cell proliferation.

Conclusions:

  • Na(+), K(+)-ATPase plays a critical role in signal transduction, mediating leukemia cell growth regulation upon ouabain binding.
  • Ouabain-induced leukemia cell proliferation is dependent on the activation of Src kinase and the ERK1/2 signaling pathway.
  • Targeting these specific pathways could offer novel therapeutic strategies for leukemia treatment.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Diversity in Cell Signaling Responses01:22

Diversity in Cell Signaling Responses

The physiological function of a cell and cellular communication are outcomes of a range of extrinsic signals, intracellular signaling pathways, and cellular responses. No two cell types express the same repertoire of signaling components. Receptors are highly selective for their cognate ligands, but once activated, they can alter multiple cellular processes such as DNA transcription, protein synthesis, and metabolic activity. 
Graded and Abrupt Responses
Some signaling systems generate...